• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染新冠病毒的年轻人的医院治疗结果。

Hospital outcomes for young adults with COVID-19.

作者信息

Williams Brian S, Piasecki Thomas M, Fiore Michael C, Conner Karen L, Slutske Wendy S

机构信息

Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health.

Division of Hospital Medicine and Complex Care, Department of Pediatrics, University of Wisconsin School of Medicine and Public Health.

出版信息

Glob Epidemiol. 2024 Jul 5;8:100155. doi: 10.1016/j.gloepi.2024.100155. eCollection 2024 Dec.

DOI:10.1016/j.gloepi.2024.100155
PMID:39100963
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11296004/
Abstract

BACKGROUND

Older adults are at higher risk of severe outcomes from COVID-19 with comorbidities increasing such risk. Much less is known about the outcomes of young adults with COVID-19 despite their having had high infection rates.

OBJECTIVES

Our objective was to determine outcomes of hospitalized young adults with COVID-19 infection including rates of oxygen use, mortality, ICU admission, intubation, duration of hospitalization, and factors associated with adverse outcomes.

STUDY DESIGN

This retrospective cohort study included EHR data from 21 health systems in the United States on 18-29-year-olds hospitalized with COVID-19 from March 1, 2020 - January 31, 2022. Oxygen need was used to identify symptomatic COVID-19. Rates for mortality, ICU admission, and intubation were calculated for the symptomatic and asymptomatic groups. Effects of demographic and health characteristics on outcomes were assessed as were changes in hospital outcomes over time.

RESULTS

Our sample included 9871 young adults hospitalized with COVID-19; 35% required oxygen. Of those who required oxygen, 53.5% were female, 23.7% had an anxiety disorder, 2.6% died ( = 89), 27.7% were admitted to the ICU ( = 955), and 15.8% were intubated ( = 547). A past-year history of any cancer was associated with a 2.1 times increased odds of death. Vaccination was associated with a >40% reduction in the odds of ICU admission. Mortality rates did not change significantly across the study period.

CONCLUSIONS

COVID-19 caused significant morbidity and mortality in hospitalized young adults who required oxygen. A cancer history was associated with increased risk of death. Vaccination appeared to have had a protective effect on illness severity.

摘要

背景

老年人感染新冠病毒后出现严重后果的风险更高,合并症会增加这种风险。尽管年轻成年人的新冠病毒感染率很高,但对他们感染新冠病毒后的结局了解较少。

目的

我们的目的是确定感染新冠病毒的住院年轻成年人的结局,包括吸氧率、死亡率、入住重症监护病房(ICU)率、插管率、住院时间以及与不良结局相关的因素。

研究设计

这项回顾性队列研究纳入了美国21个医疗系统在2020年3月1日至2022年1月31日期间收治的18至29岁新冠病毒感染住院患者的电子健康记录(EHR)数据。通过是否需要吸氧来确定有症状的新冠病毒感染。计算有症状和无症状组的死亡率、入住ICU率和插管率。评估人口统计学和健康特征对结局的影响以及医院结局随时间的变化。

结果

我们的样本包括9871名感染新冠病毒的住院年轻成年人;35%需要吸氧。在需要吸氧的患者中,53.5%为女性,23.7%患有焦虑症,2.6%死亡(n = 89),27.7%入住ICU(n = 955),15.8%接受插管(n = 547)。过去一年有任何癌症病史会使死亡几率增加2.1倍。接种疫苗与入住ICU几率降低40%以上相关。在整个研究期间,死亡率没有显著变化。

结论

新冠病毒给需要吸氧的住院年轻成年人带来了显著的发病和死亡情况。癌症病史与死亡风险增加相关。接种疫苗似乎对疾病严重程度有保护作用。

相似文献

1
Hospital outcomes for young adults with COVID-19.感染新冠病毒的年轻人的医院治疗结果。
Glob Epidemiol. 2024 Jul 5;8:100155. doi: 10.1016/j.gloepi.2024.100155. eCollection 2024 Dec.
2
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Association of hypothyroidism with outcomes in hospitalized adults with COVID-19: Results from the International SCCM Discovery Viral Infection and Respiratory Illness Universal Study (VIRUS): COVID-19 Registry.甲状腺功能减退与COVID-19住院成人患者预后的关联:国际危重病医学学会发现病毒感染与呼吸道疾病通用研究(VIRUS):COVID-19注册研究结果
Clin Endocrinol (Oxf). 2024 Jul;101(1):85-93. doi: 10.1111/cen.14699. Epub 2022 Mar 2.
5
Difference in determinants of ICU admission and death among COVID-19 hospitalized patients in two epidemic waves in Portugal: possible impact of healthcare burden and hospital bed occupancy on clinical management and outcomes, March-December 2020.葡萄牙两波 COVID-19 住院患者 ICU 入院和死亡的决定因素差异:医疗负担和病床占用对临床管理和结局的可能影响,2020 年 3 月至 12 月。
Front Public Health. 2023 Jun 29;11:1215833. doi: 10.3389/fpubh.2023.1215833. eCollection 2023.
6
The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems.COVID-19 大流行的头 20 个月:21 个美国医疗系统中 104590 名住院患者的死亡率、插管率和 ICU 入住率。
PLoS One. 2022 Sep 28;17(9):e0274571. doi: 10.1371/journal.pone.0274571. eCollection 2022.
7
Assessment of Clinical Outcomes Among Children and Adolescents Hospitalized With COVID-19 in 6 Sub-Saharan African Countries.撒哈拉以南非洲 6 国儿童和青少年 COVID-19 住院患者临床结局评估。
JAMA Pediatr. 2022 Mar 1;176(3):e216436. doi: 10.1001/jamapediatrics.2021.6436. Epub 2022 Mar 7.
8
Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.2021 年 7 月 15 日至 9 月 23 日和 2021 年 12 月 21 日至 2022 年 1 月 27 日期间,加利福尼亚州一家医院因实验室确诊的 SARS-CoV-2 感染住院的成年人的临床特征和结局,期间 B.1.617.2(德尔塔)和 B.1.1.529(奥密克戎)变异株占主导地位。
MMWR Morb Mortal Wkly Rep. 2022 Feb 11;71(6):217-223. doi: 10.15585/mmwr.mm7106e2.
9
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
10
Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.成人因实验室确诊的 COVID-19 住院的严重程度在 SARS-CoV-2 B.1.617.2(Delta)流行之前和期间-COVID-NET,14 个州,2021 年 1 月至 8 月。
MMWR Morb Mortal Wkly Rep. 2021 Oct 29;70(43):1513-1519. doi: 10.15585/mmwr.mm7043e1.

本文引用的文献

1
The Relationship of COVID-19 Vaccination with Mortality Among 86,732 Hospitalized Patients: Subpopulations, Patient Factors, and Changes over Time.《86732 例住院患者中 COVID-19 疫苗接种与死亡率的关系:亚组人群、患者因素和随时间的变化》
J Gen Intern Med. 2023 Apr;38(5):1248-1255. doi: 10.1007/s11606-022-08007-0. Epub 2023 Jan 18.
2
Association of Remdesivir Treatment With Mortality Among Hospitalized Adults With COVID-19 in the United States.美国 COVID-19 住院成人患者中瑞德西韦治疗与死亡率的关联。
JAMA Netw Open. 2022 Dec 1;5(12):e2244505. doi: 10.1001/jamanetworkopen.2022.44505.
3
The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems.COVID-19 大流行的头 20 个月:21 个美国医疗系统中 104590 名住院患者的死亡率、插管率和 ICU 入住率。
PLoS One. 2022 Sep 28;17(9):e0274571. doi: 10.1371/journal.pone.0274571. eCollection 2022.
4
Relations of Current and Past Cancer with Severe Outcomes among 104,590 Hospitalized COVID-19 Patients: The COVID EHR Cohort at the University of Wisconsin.104590 名住院 COVID-19 患者中当前和既往癌症与严重结局的关系:威斯康星大学 COVID EHR 队列。
Cancer Epidemiol Biomarkers Prev. 2023 Jan 9;32(1):12-21. doi: 10.1158/1055-9965.EPI-22-0500.
5
Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.帕克洛维德降低高危患者的严重 2019 冠状病毒病和死亡率的有效性。
Clin Infect Dis. 2023 Feb 8;76(3):e342-e349. doi: 10.1093/cid/ciac443.
6
Estimating COVID-19 Hospitalizations in the United States With Surveillance Data Using a Bayesian Hierarchical Model: Modeling Study.利用贝叶斯分层模型从监测数据估算美国的 COVID-19 住院人数:建模研究。
JMIR Public Health Surveill. 2022 Jun 2;8(6):e34296. doi: 10.2196/34296.
7
Effectiveness of mRNA Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death - United States, March 2021-January 2022.mRNA 疫苗接种在预防 COVID-19 相关有创机械通气和死亡方面的有效性-美国,2021 年 3 月-2022 年 1 月。
MMWR Morb Mortal Wkly Rep. 2022 Mar 25;71(12):459-465. doi: 10.15585/mmwr.mm7112e1.
8
Characteristics, Vaccination Status and Outcomes Among Healthy Younger Adults in a Large Public Healthcare System in the South Florida Region.南佛罗里达州大型公立医疗系统中健康年轻成年人的特征、疫苗接种状况和结局。
J Community Health. 2022 Apr;47(2):371-377. doi: 10.1007/s10900-022-01062-y. Epub 2022 Jan 21.
9
Risk factors for COVID-19 progression and mortality in hospitalized patients without pre-existing comorbidities.无合并症住院患者 COVID-19 进展和死亡的危险因素。
J Infect Public Health. 2022 Jan;15(1):13-20. doi: 10.1016/j.jiph.2021.11.012. Epub 2021 Nov 18.
10
Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence.既往健康状况与严重 COVID-19 结局:全球证据的伞式评价方法和荟萃分析。
BMC Med. 2021 Aug 27;19(1):212. doi: 10.1186/s12916-021-02058-6.